Skip to main content
. 2020 Jan 21;39(2):804–812. doi: 10.1002/nau.24285

Table 1.

Baseline characteristics of patients (FAS): mean (SD)

TG TMG Total
N N N
Age, y 72.3 (8.0) 80 72.4 (7.4) 81 72.3 (7.7) 161
Prostate volume, mL 30.5 (12.8) 75 32.1 (13.1) 77 31.3 (12.9) 152
OABSS
Total score 8.0 (2.7) 80 8.5 (2.5) 81 8.3 (2.6) 161
Daytime frequency score 1.0 (0.5) 80 1.1 (0.5) 81 1.1 (0.5) 161
Nighttime frequency score 2.1 (1.0) 80 2.2 (0.8) 81 2.2 (0.9) 161
Urgency score 3.2 (1.0) 80 3.3 (1.0) 81 3.2 (1.0) 161
Urgency incontinence score 1.8 (1.5) 80 1.9 (1.4) 81 1.8 (1.4) 161
IPSS
Total score 13.6 (6.8) 80 13.5 (5.9) 81 13.6 (6.3) 161
Voiding symptom score 4.6 (4.4) 80 4.5 (4.1) 81 4.5 (4.2) 161
Storage symptom score 7.7 (2.9) 80 7.8 (2.7) 81 7.7 (2.8) 161
Postmicturition symptom score 1.4 (1.5) 80 1.3 (1.3) 81 1.3 (1.4) 161
QOL index 4.5 (1.0) 80 4.4 (1.0) 81 4.4 (1.0) 161
NIH‐CPSI
Total score 12.4 (5.7) 80 12.3 (5.4) 81 12.3 (5.6) 161
Pain or discomfort score 1.7 (3.1) 80 1.4 (2.7) 81 1.5 (2.9) 161
Impact of symptoms score 3.8 (2.3) 80 3.7 (2.3) 81 3.7 (2.3) 161
QOL score 6.9 (2.5) 80 7.2 (2.3) 81 7.1 (2.4) 161
Micturition chart
Number of voids per 24 h 11.8 (4.0) 79 11.5 (3.3) 79 11.7 (3.7) 158
Number of nighttime voids 2.4 (1.4) 79 2.4 (1.3) 79 2.4 (1.3) 158
Number of urgency episodes 2.8 (3.4) 79 2.6 (2.9) 78 2.7 (3.1) 157
Number of urgency incontinence episodes 1.1 (2.3) 79 0.9 (1.8) 79 1.0 (2.1) 158
Uroflowmetry
Voided volume, mL 177.4 (84.2) 80 171.3 (89.8) 81 174.4 (86.9) 161
Qmax, mL/s 13.2 (5.7) 80 12.7 (5.8) 81 13.0 (5.7) 161
Qave, mL/s 7.7 (3.7) 79 7.0 (3.0) 81 7.3 (3.3) 160
PVR, mL 28.9 (20.1) 80 32.0 (28.1) 81 30.4 (2.6) 161
VE (%) 84.9 (11.5) 80 82.8 (14.2) 81 83.9 (12.9) 161

Abbreviations: FAS, full analysis set; IPSS, international prostate symptom score; NIH‐CPSI, NIH‐chronic prostatitis symptom index; OABSS, overactive bladder symptom score; PVR, postvoid residual.